Organogenesis Holdings (ORGO) Operating Leases (2021 - 2026)

Organogenesis Holdings' Operating Leases history runs 6 years deep, the most recent figure standing at $21.8 million for Q1 2026.

• On a quarterly basis, Operating Leases fell 14.98% year-over-year to $21.8 million in Q1 2026; TTM through Mar 2026 was $21.8 million, a 14.98% decrease from a year earlier, with the FY2025 full-year figure at $22.5 million, down 10.83% from the prior year.
• Operating Leases eased to $21.8 million in Q1 2026 per ORGO's latest filing, from $22.5 million in the prior quarter.
• Across five years, Operating Leases topped out at $45.3 million in Q1 2022 and bottomed at $20.9 million in Q4 2022.
• The 5-year median for Operating Leases is $25.1 million (2023), against an average of $30.1 million.
• Biggest YoY gain for Operating Leases was 77.58% in 2022; the steepest drop was 55.33% in 2022.
• Year by year, Operating Leases stood at $20.9 million in 2022, then increased by 19.6% to $25.1 million in 2023, then climbed by 0.58% to $25.2 million in 2024, then decreased by 10.83% to $22.5 million in 2025, then declined by 3.04% to $21.8 million in 2026.
• Per Business Quant, the three latest ORGO Operating Leases figures stand at $21.8 million (Q1 2026), $22.5 million (Q4 2025), and $23.5 million (Q3 2025).